{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:30:39Z","timestamp":1740807039072,"version":"3.38.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.brachy.2024.12.003","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T08:49:05Z","timestamp":1740732545000},"page":"301-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-657X","authenticated-orcid":false,"given":"Osama","family":"Mohamad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakaria El","family":"Kouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-0495","authenticated-orcid":false,"given":"Ramez","family":"Kouzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungtaek","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quynh-Nhu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Comron J","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4725-2937","authenticated-orcid":false,"given":"Ryan J","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1622-8443","authenticated-orcid":false,"given":"Shalin Jyotindra","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean Eric","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren Layer","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-4465","authenticated-orcid":false,"given":"Yusung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-8054","authenticated-orcid":false,"given":"Surendra","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9550-9333","authenticated-orcid":false,"given":"Sarath","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat J","family":"Kudchadker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa Lorraine","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-7884","authenticated-orcid":false,"given":"Steven Jay","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.12.003_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0360-3016(95)00063-5","article-title":"Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone","volume":"32","author":"Shipley","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2024.12.003_bib0002","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ijrobp.2010.01.006","article-title":"Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?","volume":"79","author":"Kuban","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2024.12.003_bib0003","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.12.003_bib0004","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2013.09.026","article-title":"Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival","volume":"110","author":"Heemsbergen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1470-2045(14)70040-3","article-title":"Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial","volume":"15","author":"Dearnaley","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0006","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1200\/JCO.21.00855","article-title":"Short androgen suppression and radiation dose escalation in prostate cancer: 12-year results of EORTC trial 22991 in patients with localized intermediate-risk disease","volume":"39","author":"Bolla","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0039","article-title":"Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trial","volume":"4","author":"Michalski","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0008","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2024.12.003_bib0009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.radonc.2015.02.023","article-title":"High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success","volume":"115","author":"Helou","year":"2015","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.brachy.2024.12.003_bib0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol: J Eur Soc Therapeut Radiol Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0011","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: An analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.12.003_bib0012","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2007.03.018","article-title":"Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison","volume":"69","author":"Trofimov","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2024.12.003_bib0013","doi-asserted-by":"crossref","unstructured":"Sosa AJ, Thames HD, Sanders JW, et al. Proton therapy for the management of localized prostate cancer: long-term clinical outcomes at a comprehensive cancer center. Radiother Oncol: J Eur Soc Therapeut Radiol Oncol 188, 109854 (2023). 10.1016\/j.radonc.2023.109854","DOI":"10.1016\/j.radonc.2023.109854"},{"key":"10.1016\/j.brachy.2024.12.003_bib0014","article-title":"Proton therapy toxicity outcomes for localized prostate cancer: long-term results at a comprehensive cancer center","volume":"48","author":"Sosa","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-20-00031.1","article-title":"Consensus statement on proton therapy for prostate cancer","volume":"8","author":"Bryant","year":"2021","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.brachy.2024.12.003_bib0016","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.brachy.2020.06.011","article-title":"Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy","volume":"19","author":"Boyce-Fappiano","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.12.003_bib0017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0019","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"Jama"},{"key":"10.1016\/j.brachy.2024.12.003_bib0020","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.ijrobp.2016.03.047","article-title":"Time course and accumulated risk of severe urinary adverse events after high- versus low-dose-rate prostate brachytherapy with or without external beam radiation therapy","volume":"95","author":"Tward","year":"2016","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.brachy.2024.12.003_bib0021","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bju.12514","article-title":"Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer","volume":"114","author":"Spratt","year":"2014","journal-title":"BJU Int."},{"key":"10.1016\/j.brachy.2024.12.003_bib0022","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/j.ijrobp.2011.11.040","article-title":"Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate","volume":"82","author":"Lawton","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2024.12.003_bib0023","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.2012.460","article-title":"Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer","volume":"307","author":"Sheets","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.brachy.2024.12.003_bib0024","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/JCO.2005.06.154","article-title":"Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate","volume":"23","author":"Sathya","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.6871","article-title":"Interplay between duration of androgen deprivation therapy and external beam radiotherapy with or without a brachytherapy boost for optimal treatment of high-risk prostate cancer: a patient-level data analysis of 3 cohorts","volume":"8","author":"Kishan","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15083","article-title":"Effect of androgen deprivation on long-term outcomes of intermediate-risk prostate cancer stratified as favorable or unfavorable: a secondary analysis of the RTOG 9408 randomized clinical trial","volume":"3","author":"Zumsteg","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.brachy.2024.12.003_bib0027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brachy.2012.03.009","article-title":"Magnetic resonance imaging-based treatment planning for prostate brachytherapy","volume":"12","author":"Albert","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.12.003_bib0028","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.brachy.2016.11.012","article-title":"Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow","volume":"16","author":"Blanchard","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.12.003_bib0029","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy","volume":"92","author":"Mariados","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2024.12.003_bib0030","article-title":"Impact of rectal spacer on toxicity reduction in men treated with proton versus photon therapy","volume":"13","author":"Dhere","year":"2024","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.brachy.2024.12.003_bib0031","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1200\/JCO.2006.09.0811","article-title":"Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?","volume":"25","author":"Konski","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.12.003_bib0032","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2017.75.5371","article-title":"Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer","volume":"36","author":"Pan","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:38:29Z","timestamp":1740746309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1538472125000017"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.12.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}